Insights

Product Portfolio Enzymotec maintains a diversified portfolio across two nutrition oriented segments and a medical foods line. This presents cross-selling opportunities to infant formula manufacturers, dietary supplement brands seeking brain health ingredients, and healthcare providers requiring medical nutrition products. Leverage established partnerships such as the InFat joint venture with AAK and Hellenia licensing to penetrate new geographies and channels. The clinically proven InFat ingredient and the brain health focus of SharpPS support compelling value propositions.

Strategic Partnerships Leverage Frutarom's global footprint and the Frutarom group ecosystem to expand distribution and co development with customers. Opportunities exist to co brand or private label lipid ingredients with infant nutrition brands and nutraceutical players. Licensing, acquisitions, or distribution agreements with partners such as Hellenia or Ushcare can accelerate market access and channel diversification.

Krill Advantage K-Real krill oil line has evolved with formulations addressing safety and regulatory concerns, including an advanced version free of harmful trimethylamine compounds. This supports selling to premium omega-3 brands, dietary supplement developers, and functional food producers seeking high purity lipid ingredients. Use recent product updates to target markets with strong demand for clean label seafood lipids.

Medical Foods Growth VAYA Pharma offers medical foods for cardiovascular and neurological management, providing a route to hospitals, clinics, specialty pharmacies, and insurer partnerships. Target healthcare providers and patient support programs to distribute end-user products, emphasizing clinical provenance and research backing to support reimbursement and formulary adoption.

Growth Readiness The company operates with a mid sized footprint and manufacturing capabilities suited for partnerships with nutraceuticals, infant nutrition, and medical nutrition brands. Focus on expanding through distribution partners, contract manufacturers, and Frutarom’s ecosystem to accelerate geography and channel expansion.

Enzymotec Tech Stack

Enzymotec uses 8 technology products and services including WordPress, Twemoji, Google Fonts API, and more. Explore Enzymotec's tech stack below.

  • WordPress
    Content Management System
  • Twemoji
    Font Scripts
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Microsoft ASP.NET
    Web Frameworks

Media & News

Enzymotec's Email Address Formats

Enzymotec uses at least 1 format(s):
Enzymotec Email FormatsExamplePercentage
First@enzymotec.comJohn@enzymotec.com
38%
FirstL@enzymotec.comJohnD@enzymotec.com
29%
First.Last@enzymotec.comJohn.Doe@enzymotec.com
24%
LastFirst@enzymotec.comDoeJohn@enzymotec.com
9%

Frequently Asked Questions

Where is Enzymotec's headquarters located?

Minus sign iconPlus sign icon
Enzymotec's main headquarters is located at Kefar Sava, Central District Israel. The company has employees across 3 continents, including AsiaEuropeNorth America.

What is Enzymotec's phone number?

Minus sign iconPlus sign icon
You can contact Enzymotec's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Enzymotec's stock symbol?

Minus sign iconPlus sign icon
Enzymotec is a publicly traded company; the company's stock symbol is ENZY.

What is Enzymotec's official website and social media links?

Minus sign iconPlus sign icon
Enzymotec's official website is enzymotec.com and has social profiles on LinkedIn.

What is Enzymotec's SIC code NAICS code?

Minus sign iconPlus sign icon
Enzymotec's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enzymotec have currently?

Minus sign iconPlus sign icon
As of April 2026, Enzymotec has approximately 91 employees across 3 continents, including AsiaEuropeNorth America. Key team members include Vp & Chief Financial Officer: O. B.Vp Process Development: G. B.President - China: L. J.. Explore Enzymotec's employee directory with LeadIQ.

What industry does Enzymotec belong to?

Minus sign iconPlus sign icon
Enzymotec operates in the Biotechnology Research industry.

What technology does Enzymotec use?

Minus sign iconPlus sign icon
Enzymotec's tech stack includes WordPressTwemojiGoogle Fonts APIjQueryModernizrLightboxBootstrapMicrosoft ASP.NET.

What is Enzymotec's email format?

Minus sign iconPlus sign icon
Enzymotec's email format typically follows the pattern of First@enzymotec.com. Find more Enzymotec email formats with LeadIQ.

Enzymotec

Biotechnology ResearchCentral District, Israel51-200 Employees

Enzymotec is a biotechnology company based in Kefar Sava, in the Central District of Israel, that develops, manufactures, and markets specialized lipid-based ingredients and related products. It operates through two segments, Nutrition and VAYA Pharma, serving the needs of infant nutrition, dietary supplements, and branded medical foods for cardiovascular and neurological conditions. In the Nutrition segment, the company offers InFat, an infant formula fat ingredient developed and sold via its Advanced Lipids joint venture with AAK, as well as SharpPS, a phospholipid-based ingredient aimed at supporting brain health. Enzymotec is part of the Frutarom Group, a globally active flavor and fine ingredients company, which situates it within the broader specialty lipids and ingredients market. In 2019, the company introduced an enhanced version of its K-Real krill oil that contains no trimethylamine or trimethylamine oxide, reflecting ongoing product refinement.

Section iconCompany Overview

Headquarters
Kefar Sava, Central District Israel
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ENZY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Enzymotec's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Enzymotec's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.